Cystatin C as risk factor for cardiovascular events and all-cause mortality in the general population. The Tromsø Study

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Renal-related biomarkers and long-term mortality in the US subjects with different coronary risks

(2011) Cho-Kai Wu et al.   ATHEROSCLEROSIS

Estimated GFR Associates with Cardiovascular Risk Factors Independently of Measured GFR

(2011) U. D. Mathisen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Cystatin C is not a better estimator of GFR than plasma creatinine in the general population

(2010) Bjørn O. Eriksen et al.   KIDNEY INTERNATIONAL

Method of Glomerular Filtration Rate Estimation Affects Prediction of Mortality Risk

(2009) B. C. Astor et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Serum Cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III)

(2008) Anna Köttgen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

(2008) Lesley A. Stevens et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Serum cystatin C is associated with other cardiovascular risk markers and cardiovascular disease in elderly men

(2007) Anders Larsson et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY